Skip to main content
Year archive

DAEWOONG PHARMA — 2026 filings

All 26 regulatory filings released by DAEWOONG PHARMA (069620) in 2026, sourced directly from the official regulator.

26 Filings
2026 Period
2026 filings (26)
Filing Released Lang
분기보고서 (2026.03)
Interim / Quarterly Report Q1 2026
2026-05-15 Korean
투자판단관련주요경영사항 (INV008(15PGDH 저해제) 기술도입 계약 체결)
Regulatory Filings
2026-05-12 Korean
영업(잠정)실적(공정공시)
Earnings Release Q1 2026
2026-05-12 Korean
투자판단관련주요경영사항 (mRNA 기반 Epigenetic Reprogramming of Aging (ERA) 기술이전 계약 지위 승계)
Regulatory Filings
2026-05-07 Korean
투자판단관련주요경영사항 (펙수클루정(Fexuclue)의 적응증 추가 국내 품목허가 승인(헬리코박터파일로리 제균을 위한 항생제 병용요법))
Regulatory Filings
2026-04-30 Korean
투자판단관련주요경영사항
Regulatory Filings
2026-04-10 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2026-03-27 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2026-03-27 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2026-03-26 Korean
최대주주등소유주식변동신고서
Major Shareholding Notification
2026-03-26 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification
2026-03-25 Korean
사업보고서 (2025.12)
Annual Report FY 2025
2026-03-18 Korean
공정거래자율준수프로그램운영현황(안내공시)
Regulatory Filings
2026-03-16 Korean
감사보고서제출
Audit Report / Information FY 2025
2026-03-09 Korean
투자판단관련주요경영사항
Regulatory Filings
2026-03-05 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2026-02-26 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2026-02-26 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2026-02-25 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount
2026-02-25 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification
2026-02-13 Korean
단일판매ㆍ공급계약해지
Regulatory Filings
2026-02-12 Korean
매출액또는손익구조30%(대규모법인은15%)이상변경
Management Reports
2026-02-09 Korean
영업(잠정)실적(공정공시)
Earnings Release Q4 2025
2026-02-09 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification
2026-01-26 Korean
투자판단관련주요경영사항
Regulatory Filings
2026-01-23 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification
2026-01-05 Korean